The company starts
Cilo Cybin Pharmaceutical is established in South Africa to pursue regulated pharmaceutical cannabis manufacturing rather than informal extract supply.
About Cilo Cybin
From pharmaceutical cannabis pioneer to the JSE Main Board.
Cilo Cybin Pharmaceutical began as a regulated medical cannabis pioneer and grew into a cannabinoid pharmaceutical platform with GMP manufacturing and listed-company governance.
Origin story
A South African cannabis pharmaceutical company built before the market was obvious.
Cilo Cybin Pharmaceutical was established in 2018, at a time when South Africa's regulated medical cannabis industry was still being defined. The company was built with a simple conviction: cannabis would only become a serious medical and pharmaceutical category if it could be processed, documented, and released through controlled systems.
The business developed a pharmaceutical manufacturing platform focused on cannabinoid extraction, refinement, formulation, packaging, quality control, and commercial supply within one accountable operating model.
Capital markets
From AltX entry to the JSE Main Board.
In 2024, Cilo Cybin Holdings entered the public markets through an AltX listing as a medical-cannabis-focused SPAC structure. The listing created a public-company platform around a regulated pharmaceutical cannabis operating business.
In 2025, the group transitioned from AltX to the JSE Main Board. That move strengthened the public-market profile of the business and positioned Cilo Cybin as a listed pharmaceutical cannabis platform with governance, reporting discipline, and regulated manufacturing capability.
The significance is not only the listing itself. It is the combination of public-company oversight with a GMP operating base spanning extraction, refinement, formulation, packaging, quality review, and partner supply under one controlled platform.
Company journey
A regulated cannabis story told through milestones.
The pharmaceutical platform expands
Cilo Cybin develops an integrated route across extraction, refinement, formulation, packaging, quality control, and commercial partner supply.
AltX listing
Cilo Cybin Holdings lists as a medical-cannabis-focused SPAC on AltX, bringing the operating platform into a public-market structure.
JSE Main Board
The group transitions to the JSE Main Board, becoming a listed pharmaceutical cannabis platform with public governance and regulated manufacturing capability.
Pharmaceutical cannabis focus
Cilo Cybin operates as a JSE-listed pharmaceutical platform focused on regulated cannabis-derived API's, bulk ingredients, finished products, and partner manufacturing.
Current platform
The story now is execution: quality, supply, and partner trust.
Today, Cilo Cybin's value sits in the connection between GMP manufacturing, API production, finished-product development, and listed-company discipline. The business is positioned for licensed partners that need cannabinoid products manufactured with traceability, documentation, and repeatable quality controls.
The leadership team brings experience across pharmaceutical manufacturing, cannabis operations, quality management, commercial execution, and regulated-company governance, supported by partnerships that extend technical capability and international market reach.
Company structure
Cilo Cybin operates through a listed holding company and a regulated pharmaceutical operating company.
The public-company layer and the GMP operating layer are connected, but they serve different roles. Holdings provides listed-company governance and shareholder reporting. Pharmaceutical carries the regulated manufacturing, product, and partner-supply capability.
Listed holding company
Cilo Cybin Holdings
Cilo Cybin Holdings is the listed holding-company platform for the group. It provides public-company governance, shareholder reporting, capital-markets discipline, and oversight for the regulated pharmaceutical cannabis operating platform.
- Legal entity
- Cilo Cybin Holdings Ltd
- Board records
- 6 directors listed
Operating pharmaceutical company
Cilo Cybin (Pty) Ltd
Cilo Cybin Pharmaceutical is the operating company behind the regulated cannabis platform. It houses the GMP manufacturing capability used for extraction, refinement, API production, formulation, packaging, quality review, and partner supply.
- Legal entity
- Cilo Cybin (Pty) Ltd
- Board records
- 4 directors listed
Holdings sub-committees
Board committee links
Holdings committee membership is shown from the same investor relations source as the board profile records.
Explore the platform
Continue through the Cilo Cybin company story.
Review the people, governance, and GMP manufacturing capability behind the pharmaceutical cannabis platform.